Axentra Corp Limited
511634Axentra Corp Limited's price has outrun its earnings. +255.7% in a year against EPS −60.2% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +255.7% in a year while annual EPS moved −60.2% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (51 weeks in) while the P/E sits at the 100th percentile of its own 1-year range. Underneath, the last four quarters read mixed, and 50% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Axentra Corp Limited trades at ₹314, in a confirmed uptrend and 51 weeks into that stage. That is +84.3% against its own 200-day average. It sits at 83% of a 52-week range of ₹25 to ₹372. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (10 weeks and counting).
Today the stock is in a confirmed uptrend — week 51 of stage 2, confirmed. At ₹314 it trades +84.3% versus its 200-day average and sits at 83% of its 52-week range (₹25–₹372).
Against the market, two honest reads. Cumulative: over the last 2.4 years the stock moved +4,882% while the NIFTY 500 moved +20% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (10 weeks and counting; last ahead the week of 2026-05-11) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Axentra Corp Limited trades at 594.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 14.6×, measured across 0.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 594.0× is about the priciest it has ever traded, against a long-run median of 14.6× measured over 0.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −60.2% against a +255.7% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Axentra Corp Limited reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +3,346.7% | — | — | — |
| Profit | +2,500.0% | +370.3% | — | +59.1% |
| EPS | −60.2% | +17.1% | — | +33.3% |
| Share price | +255.7% | — | — | — |
4-Factor Sector Score
42.4/100 — rank 4 of 5 in Construction - Factories/Offices/Commercial · 42% evidence confidence · provisional, ranked below fully-evidenced peers
Axentra Corp Limited scores 42.4 out of 100 against the 5 companies it is compared with in Construction - Factories/Offices/Commercial, ranking 4. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 14.5 + 7 + 10 + 10.9 = 42.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Axentra Corp Limited reported ₹10.3 Cr of revenue in the Mar 26 quarter. The last full year, FY26, came in at ₹10.3 Cr. The last four reported quarters add to ₹10.3 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY26 revenue came in at ₹10.3 Cr (+3,346.7% on the year). The latest quarter (Mar 26) printed ₹10.3 Cr, null year on year.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Axentra Corp Limited's operating margin is 10.9% in the Mar 26 quarter. Across 3 fiscal years the operating margin has ranged 7.0% to 40.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 10.9%, null pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 7.0%–40.0%.
Why: the numbers show the operating margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Axentra Corp Limited earned ₹1.3 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹1.0 Cr. The 10-year compound rate is 59.1%. That is 12.3% of the quarter's revenue. The same quarter a year earlier lost ₹0.01 Cr. 10 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹1.3 Cr, null year on year. On the full year, FY26 printed ₹1.0 Cr (+2,500.0%), and the 10-year compound rate is 59.1%.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 50% of Axentra Corp Limited's reported profit arrived as operating cash — a gap worth watching. In FY25 that was ₹0.1 Cr of operating cash against ₹0.0 Cr of profit. After ₹0.0 Cr of capital spending, ₹0.0 Cr was left as free cash.
FY25: operating cash of ₹0.1 Cr against reported profit of ₹0.0 Cr, leaving free cash of ₹0.0 Cr after ₹0.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 50% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 50%: the cash cycle tightened 217 days between FY17 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Axentra Corp Limited's cash conversion cycle runs 367 days in FY26, down from 584 days in FY17. Capital spending ran ₹0.0 Cr over the last 3 years. At FY26 sales of ₹10.3 Cr each day of that cycle holds about ₹0.0 Cr, so roughly ₹10.0 Cr sits inside the business at any moment.
FY26: debtors at 367 days (an asset-light business — no inventory to speak of) — for a full cycle of 367 days, tighter than FY17's 584.
In money terms: at FY26 sales of ₹10.3 Cr, each day of the cycle holds about ₹0.0 Cr — so the 367-day loop keeps roughly ₹10.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹0.0 Cr over the last 3 fiscal years. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Axentra Corp Limited earns a ROCE of 7% in FY26. That is up from a trough of −3,000% in FY18. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 10.1% net margin on 0.25× asset turns.
FY26 ROCE is 7%, recovered from a FY18 trough of −3,000% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 10.1% net margin × 0.25× asset turns × 1.32× balance-sheet leverage ≈ 3.3% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Axentra Corp Limited carries ₹1.1 Cr of borrowings against ₹31.3 Cr of equity in FY26, a debt-to-equity of 0.03. Operating profit covers the interest bill 72×. Over 5 years borrowings went from ₹0.0 Cr to ₹1.1 Cr. Capital spending ran ₹0.0 Cr across the last 3 of those years.
FY26: borrowings of ₹1.1 Cr against equity of ₹31.3 Cr — a debt-to-equity of 0.03. Operating profit covers the interest bill 72×. Over 5 years borrowings went from ₹0.0 Cr to ₹1.1 Cr while capital spending ran ₹0.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 58.6 points of Axentra Corp Limited over 8 quarters, the biggest move on the register. That takes foreign institutions to 58.6% of the company. Promoters moved −4.1 points over the same window, to 30.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +58.6 points over 8 quarters to 58.6%; Promoters: −4.1 points over 8 quarters to 30.5%.
Why the register moved: foreign institutions drove it (+58.6 points), absorbed on the other side by promoters (−4.1 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Axentra Corp Limited: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Shraddha Prime Projects LtdSHRADDHA | 50.9/100Mixed-positive evidence62% evidence | 23.0/35 Revenue 100% · PAT 100% · OPM change -10 pp 83% evidence | 14.0/25 ROCE 16.3% · OPM 16% 76% evidence | 10.0/20 P/E 18× · PEG — 0% evidence | 3.9/20 RS sector -51% · RS bench 0% · 1Y -2.6%4 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 23 + 14 + 10 + 3.9 = 50.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -51% and the one-year return is -2.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 2Sri Lotus Developers & Realty LtdLOTUSDEV | 45.8/100Mixed-negative evidence75% evidence | TURNING | 10.2/35 Revenue 39.8% · PAT 7% · OPM change -18 pp 100% evidence | 17.8/25 ROCE 21.2% · OPM 39% 100% evidence | 7.7/20 P/E 41.2× · PEG 2.23 50% evidence | 10.1/20 RS sector — · RS bench 25.2% · 1Y -4.6%5 of 10 weeks ahead 25% evidence |
| Exact sum: 10.2 + 17.8 + 7.7 + 10.1 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3B-Right RealEstate Ltd543543 | 71.0/100Thin evidence · provisional48% evidence | ASLEEP | 24.9/35 Revenue 100% · PAT 100% · OPM change 30 pp 48% evidence | 20.9/25 ROCE 21.6% · OPM 41% 76% evidence | 13.5/20 P/E 26× · PEG — 35% evidence | 11.7/20 RS sector — · RS bench 30.1% · 1Y 236.4%4 of 12 weeks ahead 25% evidence |
| Exact sum: 24.9 + 20.9 + 13.5 + 11.7 = 71 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Axentra Corp Limitedthis page511634 | 42.4/100Thin evidence · provisional42% evidence | 14.5/35 Revenue 100% · PAT 100% · OPM change — 52% evidence | 7.0/25 ROCE 6.9% · OPM 10.9% 76% evidence | 10.0/20 P/E 594× · PEG — 0% evidence | 10.9/20 RS sector — · RS bench 27.6% · 1Y 255.7%0 of 4 weeks ahead 25% evidence | |
| Exact sum: 14.5 + 7 + 10 + 10.9 = 42.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Avishkar Infra Realty Ltd508929 | 34.4/100Thin evidence · provisional47% evidence | 7.0/35 Revenue -80% · PAT -80% · OPM change — 76% evidence | 4.9/25 ROCE 2.3% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 45.3% · 1Y 242.1%0 of 2 weeks ahead 25% evidence | |
| Exact sum: 7 + 4.9 + 10 + 12.5 = 34.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Axentra Corp Limited's share price today?
Axentra Corp Limited trades at ₹314, +255.7% over the past year. The company is valued at ₹618 Cr. The stock sits at 83% of its 52-week range of ₹25–₹372, +84.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 51 weeks in. — as of 31 July 2026.
What were Axentra Corp Limited's latest quarterly results?
Axentra Corp Limited reported revenue of ₹10.3 Cr and net profit of ₹1.3 Cr for the Mar 26 quarter. Earnings per share were ₹0.64. The operating margin was 10.9%. — as of 31 July 2026.
What is Axentra Corp Limited's revenue?
Axentra Corp Limited reported revenue of ₹10.3 Cr in the Mar 26 quarter. For the full FY26 fiscal year, revenue was ₹10.3 Cr (+3,346.7%). — as of 31 July 2026.
What is Axentra Corp Limited's profit?
Axentra Corp Limited earned ₹1.3 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹1.0 Cr. The operating margin ran 10.9% in the latest quarter. — as of 31 July 2026.
What is Axentra Corp Limited's market cap?
Axentra Corp Limited's market capitalisation is ₹618 Cr at a share price of ₹314. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Axentra Corp Limited's P/E ratio?
Axentra Corp Limited trades at a P/E of 594.0×, at the 100th percentile of its own 1-year range, against a long-run median of 14.6×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Axentra Corp Limited pay a dividend?
No — Axentra Corp Limited has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Axentra Corp Limited overvalued?
On its own history, Axentra Corp Limited looks expensive against its own history: its P/E of 594.0× sits at the 100th percentile of its 1-year range (long-run median 14.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
How is Axentra Corp Limited performing?
Axentra Corp Limited is in a confirmed uptrend, 51 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Axentra Corp Limited in an uptrend?
Yes — the price is in a confirmed uptrend (week 51 of stage 2), trading +84.3% versus its 200-day average and at 83% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Axentra Corp Limited beating the market?
Not lately — on a trailing-13-week view Axentra Corp Limited is currently behind the NIFTY 500 (10 weeks and counting; last ahead the week of 2026-05-11), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 2.4 years the stock moved +4,882% against the NIFTY 500's +20% — ahead of the index over the full window. — as of 31 July 2026.
Will Axentra Corp Limited's share price go up?
This page publishes no price forecast for Axentra Corp Limited. What it measures instead: the share price is ₹314, the price is in a confirmed uptrend 51 weeks in. Its P/E of 594.0× sits at the 100th percentile of its own 1-year range. — as of 31 July 2026.
Who owns Axentra Corp Limited?
Promoters hold 30.5% of Axentra Corp Limited, foreign institutions 58.6%, domestic institutions null% and the public 10.9% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 58.6 points over 8 quarters. — as of 31 July 2026.
Does Axentra Corp Limited have too much debt?
No — Axentra Corp Limited's debt-to-equity is 0.03, and operating profit covers the interest bill 72×. FY26 borrowings were ₹1.1 Cr against equity of ₹31.3 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Axentra Corp Limited's capex?
Axentra Corp Limited spent ₹0.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹0.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Axentra Corp Limited's cash flow?
Axentra Corp Limited generated ₹0.1 Cr of operating cash flow in FY25 and ₹0.0 Cr of free cash flow after ₹0.0 Cr of capital spending. Reported profit that year was ₹0.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Axentra Corp Limited's profit real cash?
Not fully — over the last 3 fiscal years, 50% of Axentra Corp Limited's reported profit arrived as operating cash. In FY25, operating cash was ₹0.1 Cr against reported profit of ₹0.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Axentra Corp Limited in its business cycle?
Axentra Corp Limited's FY26 operating margin was 7.0%, against a 3-year band of 7.0%–40.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 10.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Axentra Corp Limited story?
The sharpest disagreement: the price moved +255.7% in a year while annual EPS moved −60.2% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Axentra Corp Limited a stock worth studying right now?
This is not investment advice. The machine read: Axentra Corp Limited's price has outrun its earnings. +255.7% in a year against EPS −60.2% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.